We investigated mechanistic differences in antigen presentation between murine MHC class I variants H-2K b and H-2K bm8. H-2K bin8 differs from H-2K b by four residues at the floor of the peptide-binding site, affecting its B pocket which interacts with the second (P2) residue of the peptide. The rest of the molecule, including the T cell receptor (TCR)-contacting residues, is identical to H-2K b. Due to this variation, CTLs that recognize the ovalbumin257_264 and HSV gB498_505 peptides on H-2K b cannot recognize them on H-2K bros. This could be due to impaired peptide binding or an altered peptide:K bin8 conformation. Peptide binding studies ruled out the first explanation 9 Molecular modehng indicated that the most obvious consequence of amino acid variation between peptide/H-2K b and peptide/H-2K bms complexes would be a loss of the conserved hydrogen bond network in the B pocket of the latter. This could cause conformational variation of bound peptides. Intermolecular second-site reversion was used to test this hypothesis: P2-substituted OVA and HSV peptides, engineered to restore the hydrogen bond network of the B pocket, were the only ones which restored CTL recognition. These results provide a molecular understanding of peptide/MHC conformational variation.
M
HC class I molecules are the most polymorphic molecules in mammals (1) . This polymorphism can influence T cell recognition by: (a) changing the class I surface that directly interacts with the TCtL; (b) changing a set ofpeptides that can be presented to the TCR.; and (c) binding the same peptide(s) in a different conformation. While the first two mechanisms are well understood (2) (3) (4) , the third one is still obscure. In theory, conformational variation could work as follows: MHC alleles X and Y differ from each other only at peptide-binding residues, and both can bind peptide A. As a consequence of differential interactions in the peptide-binding site, A/X and A/Y would structurally differ from each other. Some of this variation may be accessible to the TCR, and TCRs that recognize A/X may not be able to recognize A/Y. Studies using MHC or peptide variants invoked conformational variation as a cause for altered T cell recognition whenever peptide: MHC binding appeared to be intact (reviewed in reference A partial and preliminary account of this work was presented at the 1993 Keystone Symposium, Taos, NM. 5). One study implicated conformational variation as a major cause for alloreactivity (6) : the same HPLC fraction eluted from H-2K bm8 and H-2K b molecules, presumably containing a shared selfpeptide(s), was differentially recognized by CTLs when bound to H-2K b versus H-2K bros. However, neither of the above studies employed methods that could reveal the structural mechanism of variation. To address this issue, we used chemically, and, in some cases, crystallographically, defined peptides and natural MHC class I variants, and the technique of intermolecular second-site reversion.
Materials and Methods
Mice, Immunization and SlCr-release Assay. C57BL/6 (B6, H-2 b) and B6.C-H-2 bins (bm8, H-2 bn~s) mice were obtained from the NCI (Frederick, MD) and Dr. J. Sprent (The Scripps Institute, La Jolla, CA), respectively. The latter were bred at the MSKCC vivarium. Peptide and virus immunization, restimulation, and 51Cr-release assay were performed exactly as described (7) .
Peptides and the Peptide:MHC Binding Assay. Peptide-MHC binding was quantified by determining relative expression of sta-ble MHC molecules on peptide transporter (TAP)-deficient cell lines in the presence of indicated peptides (8) . The peptides OVA (SIINFEKL), O2E (SEINFEKL), O2A (SAINFEKL), O2D (SDIN-FEKL), HSV (SSIEFARs H2E (SEIEFARL), and HIV (R.G-PGRAFVTI) were f-moc-synthesized, and HPLC purified to >95% purity (MSKCC Microchemistry Core Facility). The RMA-S cell Immuline and its H-2Kb-loss variant (a gift of Drs. J. Rogers and R.P,.
Strain nization Rich, Baylor University, Houston, TX) transfected with the H-2K bin8 cDNA (from Dr. L. Pease, Mayo Clinic, Rochester, MN) B6 OVA were used for the assays, which were performed exactly as previously described (8) . % maximal stabilization was calculated relative to the levels of total (empty and peptide-associated) H-2K b and H-2K bins at 29~ as: (MFI with peptide at 37~ -MFI without peptide at 37~ at 29~ -MFI without peptide at 37~ • 100, where MFI = mean fluorescence intensity. Results were corroborated using competitive inhibition of CTL lysis.
Computer Modeling of the Peptide:MHC Complexes. Figures were generated using RIBBONS (9) . All three models (Fig. 2, b-d) were generated by TOM (10), based on the crystal structure of OVA/ B6 HSV K b (11) (Fig. 2 a) , using preferred side chain rotamers. Energy minimization studies, performed using Biosym (San Diego, CA) software, indicated that the models were energetically favorable. Table 1 ). These two peptides share the same principal anchor residues, in positions five and eight (P5F and P8L), and a medium-size residue at P2 (I and S, respectively). P5F and a medium-size residue at P2 (in contrast to tyrosine [P5Y] and a small P2 residue in H-2Kb-binding peptides VSV [RGYVYQGL] and SEV [FAPGNYPAL]) characterize the "OVA" submotifofH-2Kb-binding peptides (11) . Peptides with this submotif contact the central H-2K b pocket C by P5F, but, unlike the VSV and SEV peptides, also interact with pocket B via P2 (11) (12) (13) . This interaction has the potential to affect T cell recognition (14, 15) .
B6 anti-OVA CTLs cannot recognize OVA when presented by H-2K bin8 (5, 16, 17, Table 1 ). HSV, another peptide with the "OVA" submotif, also failed to be recognized when presented by H-2K bin8 (Table 1) . H-2K bin8 differs from H-2K b by three [~-strand substitutions, Y22---)F, M23--+I, and E24---~S, and a loop substitution A30-+N (18) , all located on the floor of the peptide binding site (11, 19) . Crystal structure analysis (11, 20) and site-directed mutagenesis (21, 22) have shown that the mutations Y22-+F and E24-+S occur in the pocket B of the peptide binding groove, where they may directly affect peptide binding, but have no solvent accessibility and thus are predicted not to interact directly with the TCR. Residues 23 and 30 point away from the peptide binding groove and are functionally irrelevant for peptide binding and TCR. recognition (12, 20, 21) .
Impaired Peptide Binding Does Not Account for the Lack of OVA/K ~ms and HSV/K bins Recognition. The inability of
CTLs were derived by peptide immunization (7). 51Cr-release assays were performed on peptide-pulsed S.B6 (H-2K b) or S.bm8 (H-2K bms) (16) target cells. The assays were performed in triplicates (absolute variation: -+3% 5lCr release) at a 10:1 E:T ratio. % specific lysis was corrected for the lysis ofunpulsed target cells (<5%). Results are representative of >20 experiments.
H-2K bm8 to present OVA and HSV could be explained by: (a) significant H-2Kbm8-induced, peptide-independent, structural changes that alter TCR contact; (b) impaired peptide binding; or (c) subtle, peptide-dependent local conformational variation of the peptide/MHC complex. H-2K b and H-2K bms are indistinguishable as assayed by a panel of conformation-sensitive mAb, directed against the Ix-helical regions of the Ixl and Ix2 domains (5, 16) . Furthermore, H-2K bin8 can present other peptides (e.g., the VSV and SEV peptide) to B6 CTLs (10, R. Dyall, unpublished data). These findings argue strongly against the first possibility.
Binding of OVA and HSV peptides to H-2K b and H-2K bm8 was tested using a class I-stabilization assay (8, Fig.  1 ). Identical results were obtained using a modified stabilization assay (not shown), that took into account the peptide off-rates (by thoroughly washing the peptide away before a 4-h incubation at 37~
The results were, therefore, representative of the binding capacity of peptides tested. HSV bound equally well to H-2K b and H-2K bin8 (Fig. 1, a  and b) . OVA did not bind to H-2K bins as well as to H-2K b (Fig. 1, c and d) . However, impaired binding alone could not explain the lack of OVA/K bin8 recognition, because even at the OVA concentration which produced substantial H-2K bm8 stabilization (10 -6 M, Fig. 1 d) , there was still no recognition of this complex (Table 1) . These results, therefore, rule out the second explanation.
Could a local structural variation explain the phenotype of H-2Kbm8? Crystal structures of H-2K b complexed to OVA (Fig. 2 a, reference 11 ), VSV and SEV (12) show that all three complexes share a conserved hydrogen bond network in the B pocket, and the HSV/K b complex is likely to preserve it (Fig. 2 b) . The substitutions Y22--)F and E24---)S in H-2K bins would be predicted to alter the conserved hydrogen bonding network (see a naive model of KbmS-HSV, Fig. 2 c) . We conclude that OVA/H-2K bm8 and HSV/H-2K bin8 complexes are unlikely to be isostructural with their H-2K b counterparts. By methocl~ employed here, it is not possible to determine which peptide and/or MHC residues would move. However, likely candidates for this predicted structural variation include the TCR.-accessible backbone atoms of peptide residues P1-P4, as well as TC1L-accessible MHC residues K66 and N70 which sit atop the B pocket.
Intermolecular Second-site Reversion Restores CTL Recognition and Provides Evidence for Conformationat Variation.
A specific prediction of this model is that the reconstitution of the hydrogen bond network in the B pocket may restore TCR recognition of peptide/K bms. To test this prediction, we adapted a genetic technique of second-site reversion (23, 24) , whereby protein (usually enzyme) point-mutants are functionally rescued by spontaneous mutations at a distant (second) site, providing information on functionally important intramolecular interactions. We used substituted peptide as an intermolecular second site. If we were correct, re-introduction of a peptide side chain of medium size, which could participate in the B pocket hydrogen bonding network, might restore the recognition of peptide/K bm8 complexes. Of several substituted OVA and HSV peptides, those bearing glutamic acid at P2 (O2E and H2E) were recognized by B6 CTLs (Table 1 (Table 1 ; not shown). It could be argued that the second-site reversion may not strictly depend on the B pocket hydrogen bond network, and that it could be achieved by other substitutions in the peptide as well. We did not test all possible peptide variants, and thus cannot formally exclude this possibility. However, we consider it highly unlikely, for two reasons. First, neither of several TCk-exposed or buried substitutions tested (O4R, O2E4E, O7E, O7Q, O4E, O5Y, H5Y, and H7K) could restore recognition (not shown). Second, OVA peptides substituted at all buried or all exposed residues with amino acids from the VSV peptide (SGYNYEKL and RIIVFQGL, respectively) also failed to restore recognition (not shown). These results strengthen the conclusion that the original K bin8 mutation and the second-site peptide substitution have to be spatially close and likely interact directly. The rescue of recognition was obtained with mono- (Fig. 3 A) , oligo- (Fig. 3 B) or polyclonal (Table 1 ) CTLs, indicating that reversion occurs for the majority ofc~OVA and otHSV CTLs, and not just for a few clones. This was reminiscent of the effect of H-2K bins on OVA presentation and positive selection, which affect the entire CTL repertoire (16, 17) . The rescue of recognition for long-term CTLs (Fig. 3 ) was more eflficient than for "primary" CTLs (Table 1) , where 2E/K bins was recognized only at high peptide concentrations (10 -8, as opposed to 10 -12 for wt/ Kb), and resulted in lower lysis levels. We explain this discrepancy by differential affinity of primary versus long-term Report The HSV/K b complex is likely to preserve the hydrogen bonds in the t3 pocket, and P2S, relative to P2I in OVA, could provide for another hydrogen bond with E24(MHC), which is predicted to occur without any significant structural rearrangements of the complex. One caveat of this model is that HSV P4E, relative to P4N in OVA, could be a source of difficult to predict structural variation. (c) Naive model of the HSV/K bin8 complex. The substitutions Y22-+F and E24--+S in H-2K bin8 are expected to dramatically affect the shape and chemistry of the B pocket. In the case of HSV/K binS, with P2S and S24(MHC), the complex is unlikely to maintain the structure presented in Fig. 2, b and c, because a large void volume would be present in the B pocket, and only three out of six hydrogen bonds could be formed. To achieve a high affinity complex, either the peptide, the MHC, or both, are probably rearranged relative to the model presented here. Peptide backbone atoms of P1-P4 and MHC residues N70 and, especially, K66 (12) (which are solvent-exposed and adjacent to the peptide) are likely candidates for this structural variation. Their variation is strongly predicted to affect TCP, recognition. (Table 1, Fig. 3 A) . The lack of recognition of OVA/ H-2K bins therefore, may be explained by peptide:MHC structural variation. Likewise, since HSV and H2E stabilized H-2K bm8 equivalently (Fig. 1 b) , conformational variation most plausibly explains why only the H2E/H-2K bin8 complex was recognized (Table 1 and Fig. 3 B) .
Conformational Variation Best Explains the Effects of H-2I~ ''8 Mutation and of Second-site Revertant Peptides on T Cell Recog
The side chain of P2 is buried in the groove, is inaccessible to the TCR, and therefore is unlikely to influence TCR recognition directly (12, 25) . Recognition of the 2E/ H-2K t'ms complexes by H-2Kb-restricted CTLs implies that these complexes could assume conformations similar to that of the wt peptide/H-2K b complexes. Indeed, computer modeling predicts that a single amino acid change of P2 to E in HSV and OVA has the potential of creating H-2K bm8 complexes which are nearly isostructural to that of HSV/ H-2K b and OVA/H-2K b, owing to the restoration of an extended hydrogen bonding network in the B pocket (Fig.  2 d) . Thus both the inability of H-2K bm8 to efficiently present OVA and HSV peptides to H-2K b restricted CTLs, and the rescue of this presentation by second-site 2E revertants, can be explained by altered physicochemical interactions in pocket B, which in turn affect the TCR-interacting surface of the peptide:MHC complex. A similar situation was found for the T4 phage lysozyme (23) , where intramolecular second-site revertants compensated for the loss of hydrogen bonds via new hydrogen-bonding interactions. By contrast to OVA and HSV, VSV and SEV peptides are presented by H-2K bin8 (17, and R. Dyall, unpubfished observation), Since the side chains of these peptides do not interact with the B pocket, they may be less affected by hydrogen bond network changes. Thus, the loss of a B pocket hydrogen bond network would influence TCR recognition in a peptide-specific manner.
Recent tide interaction is not static. MHC side chains have been observed to adopt different rotamers when associated with different peptides (11, 12, 26, 27) . Peptide-associated changes in the class I:peptide complex could also be detected by monoclonal antibodies directed at different parts of the oq and a 2 domains (28) (29) (30) , and some may have been induced by indirect, conforrnational effects (30) . Consistent with the above reports, and the one on the role of conformational variation in alloreactivity (6), our results make a strong case for the influence of MHC:peptide conformational variation on TCR recognition of H-2K bin8 and the role of the B pocket hydrogen bonding network in it.
